177Lu-NM600 targeted radionuclide therapy extends survival in syngeneic murine models of triple-negative breast cancer.
Title: | 177Lu-NM600 targeted radionuclide therapy extends survival in syngeneic murine models of triple-negative breast cancer. |
---|---|
Authors: | Hernandez, Reinier, Grudzinski, Joseph J., Aluicio-Sarduy, Eduardo, Massey, Christopher F., Pinchuk, Anatoly N., Bitton, Ariana N., Patel, Ravi, Zhang, Ray, Kumar, Aakarsha V., Iyer, Gopal, Engle, Jonathan W., Weichert, Jamey P. |
Source: | Journal of Nuclear Medicine; Dec2019, Vol. 60 Issue 12, p1-25, 32p |
Database: | Complementary Index |
ISSN: | 01615505 |
---|---|
DOI: | 10.2967/jnumed.119.236265 |
Published in: | Journal of Nuclear Medicine |
Language: | English |